PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.79 +0.04 (+2.29%)
At close: Oct 2, 2026 · 4:00 PM EDT

PMV Pharmaceuticals (PMVP) Selling, General & Administrative (2019 - 2026)

Updated

PMV Pharmaceuticals (PMVP) posted Selling, General & Administrative of $4.21 million for Q2 2026, down 6.1% from $4.48 million a year earlier but up 14.0% from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Selling, General & Administrative (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at PMV Pharmaceuticals was $15.62 million, down 37.4% year-over-year; for FY2025, it was $16.33 million, down 39.3% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 8.2% (FY2020 to FY2025).
  • In prior years, PMV Pharmaceuticals' Selling, General & Administrative was $26.92 million in FY2024 (+11.0%), $24.25 million in FY2023 (-3.2%), $25.05 million in FY2022 (+14.9%) and $21.8 million in FY2021 (+98.0%).
  • Quarterly Selling, General & Administrative has run from a low of $3.42 million in Q4 2025 to a high of $11.4 million in Q4 2024 over five years.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last six quarters, with an average decline of 6.0% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 119.1%; the weakest was Q4 2025, with a decline of 70.0%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $3.69 million (Q1 2026), $3.42 million (Q4 2025) and $4.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 PMV Pharmaceuticals 95.69 Mn -319.48 Mn - 4.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.21 Mn
Mar 31, 2026 3.69 Mn
Dec 31, 2025 3.42 Mn
Sep 30, 2025 4.31 Mn
Jun 30, 2025 4.48 Mn
Mar 31, 2025 4.12 Mn
Dec 31, 2024 11.40 Mn
Sep 30, 2024 4.94 Mn
Jun 30, 2024 5.54 Mn
Mar 31, 2024 5.04 Mn
Dec 31, 2023 5.52 Mn
Sep 30, 2023 6.04 Mn
Jun 30, 2023 6.28 Mn
Mar 31, 2023 6.41 Mn
Dec 31, 2022 6.14 Mn
Sep 30, 2022 5.71 Mn
Jun 30, 2022 6.42 Mn
Mar 31, 2022 6.78 Mn
Dec 31, 2021 6.31 Mn
Sep 30, 2021 5.94 Mn
API Access

PMV Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PMVP&period=max&api_key=YOUR_API_KEY